Kezar Life Sciences Inc. (NASDAQ: KZR) Stock Information | RedChip

Kezar Life Sciences Inc. (NASDAQ: KZR) Listen to this Section


$0.61
-0.0099 ( -1.59% ) 188.6K

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Market Data


Open


$0.61

Previous close


$0.62

Volume


188.6K

Market cap


$44.76M

Day range


$0.61 - $0.64

52 week range


$0.54 - $1.69

Insider Ownership Transactions

Total Amount Purchased: -1,751,688.00 | $ -1,076,762.61

Date Type Amount Purchased Purchaser
2024-07-26 Sale -6688.00 Schiller Mark C.
2024-06-21 Sale -50000.00 Wallace Courtney
2024-06-21 Sale -50000.00 Klearman Micki
2024-06-21 Sale -50000.00 Kauffman Michael
2024-06-21 Sale -50000.00 Garner Elizabeth
2024-06-21 Sale -50000.00 COOPER GRAHAM K
2024-06-21 Sale -50000.00 BERGER FRANKLIN M
2024-01-09 Sale -295000.00 Belsky Marc
2024-01-09 Sale -275000.00 Mordwinkin Nicholas Michael
2023-11-09 Sale -875000.00 Kirk Christopher J.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 77 Aug 13, 2024
8-k 8K-related 12 Aug 13, 2024
4 Insider transactions 1 Jul 26, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
8-k 8K-related 11 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.